For serum samples, 75 L of chloroform:methanol extraction solvent (v:v = 1:2) was added to 20 L of mouse serum, with the exception of the serum from WT, Gclc L-KO, Nrf2 L-KO, and L-DKO mouse serum, for which 20 L of mouse serum was combined with 180 L of chloroform:methanol extraction solvent (v:v = 1:2) containing internal standards at the final concentrations: 5 nM D7-Sphinganine (Avanti Polar Lipids Inc., Cat# 860658), 12.5 nM D3-Deoxysphinganine (Avanti Polar Lipids Inc., Cat# 860474), and SPLASH LIPIDOMIX (1:1000, Avanti Polar Lipids Inc., Cat# 330707)
Semaglutide is a cutting-edge medication designed to address weight management
The concurrent use of semaglutide with other antidiabetic agents requires careful clinical management to balance glycemic control against hypoglycemia risk
Clinical trials have shown that individuals using Semaglutide experience steady and sustained weight loss without the extreme restrictions required by many traditional diets